Abstract 14878: Relationship of Serum Erythropoietin Level to Clinical Outcome in Acute Heart Failure Patients without Anemia
Takehiro Homma, Toshihisa Anzai(Hokkaido University), Kenji Nakamura(Chiba University), Tatsuhiro Shibata(United Cerebral Palsy), Satoshi Yasuda(Tohoku University), Takeshi Aiba(National Cerebral and Cardiovascular Center), Hisao Ogawa(Kumamoto University Hospital), Takafumi Yamane, Toshiyuki Nagai(Hokkaido University), Teruo Noguchi(National Cerebral and Cardiovascular Center), Yasuhide Asaumi(National Cerebral and Cardiovascular Center), Kengo Kusano(Northwestern University), Masaharu Ishihara(Hyogo Medical University), Daigo Chinen, Naotsugu Iwakami(Kyoto University), Yasuo Sugano(keiyu Hospital)
Cited by 0
Related Papers
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
|New England Journal of Medicine|2017|9.1k
Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure.
|Circulation|1994|1.3k
Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial
|The Lancet|2017|1.3k
Thrombin-Receptor Antagonist Vorapaxar in Acute Coronary Syndromes
|New England Journal of Medicine|2011|755